History, however, offers a useful caution. Breakthrough technologies in medicine rarely achieve their full potential simply because they exist. Their real impact depends on whether the institutions responsible for health-care delivery know how to adopt them wisely, integrate them responsibly and align them with their mission to improve patient health.

Artificial intelligence now stands at that same threshold. The industry has moved beyond fascination with what algorithms can do and entered a more demanding phase: determining how these tools should be evaluated, governed, and integrated into the environments where care is delivered. At the same time, some health professionals are turning to AI – not to augment their knowledge – but assuming the information is patient-care ready.

Across the health ecosystem, leaders are discovering that the most important questions about artificial intelligence are not technological. They are organizational, ethical and operational. Which AI systems genuinely improve clinical decision-making? Which tools strengthen the efficiency of hospitals and health systems? Which innovations introduce complexity without delivering measurable benefit?

Answering those questions requires a perspective that bridges policy leadership, real-world care delivery, and the scientific foundations of biomedical informatics. That convergence of experience sits at the center of a “Views From the Top” mainstage discussion at the HIMSS Global Health Conference & Exhibition, where some 35,000 leaders whose work spans the global health ecosystem will examine how organizations can recognize the true value proposition of artificial intelligence applications before embedding them into health-care systems.

The perspectives shaping this discussion reflect three essential dimensions of responsible artificial intelligence in health: governance frameworks that guide innovation, operational insights from large-scale health care delivery, and scientific rigor grounded in biomedical informatics. Together, these vantage points illuminate the path from technological promise to practical value.

Governing Innovation in a Rapidly Changing Health Ecosystem

Digital transformation in health rarely succeeds simply because technology exists. It succeeds when organizations develop leadership frameworks capable of evaluating innovation, managing risk and aligning new tools with patient-centered goals.

Few leaders have observed the evolution of digital health across as many national systems and institutional environments as Hal Wolf, president and chief executive officer of HIMSS, Ran Balicer, MD, PhD, chief innovation officer of Clalit Health Services and Isaac Kohane, MD, PhD, chair of biomedical informatics at Harvard Medical School. The three will step onto the mainstage at HIMSS to share their “View from the Top” in a session titled: “Recognizing the ‘Value Proposition’ Criteria While Selecting AI Applications.”

Through his work with global government health ministries, hospital networks, and technology innovators worldwide, Wolf has consistently emphasized that technological progress must be anchored in governance and trust.

“Digital health transformation is not about technology alone. It is about leadership, governance, and the trust that allows innovation to improve care,” Wolf has said in discussions about global digital health transformation.

Artificial intelligence intensifies this leadership challenge because its influence extends far beyond traditional clinical tools. AI systems increasingly operate across multiple layers of healthcare delivery. Some applications assist clinicians by analyzing medical data or suggesting treatment options. Others function within hospitals’ and health systems’ operational infrastructure, helping manage patient flow, prioritize diagnostic reviews, and allocate scarce resources.

These operational algorithms rarely capture headlines; however,  they shape the environment in which health care is delivered. Decisions about which cases are reviewed first, how clinicians allocate their attention, and how health systems manage capacity can profoundly influence patient outcomes.

For leaders responsible for health systems, artificial intelligence cannot be treated as simply another technological upgrade. It must be evaluated through governance structures capable of understanding how algorithms function, what assumptions shape their recommendations, and how their use aligns with institutional priorities.

Without that oversight, innovation risks amplifying complexity rather than improving care. Instead of informing, it can spread misinformation.

Aligning Artificial Intelligence With the Values of Medicine

Governance provides the policy foundation for responsible adoption of artificial intelligence, but real-world implementation reveals a second challenge: ensuring that AI systems operate effectively within healthcare delivery itself.

Large population health systems increasingly use advanced analytics to anticipate risk, manage chronic disease, and allocate clinical resources across diverse communities. Within these environments, artificial intelligence is no longer a theoretical innovation. It is already influencing how health organizations prioritize patients, coordinate care and deploy limited resources.

That operational perspective is central to Ran Balicer, MD, PhD, of Clalit Health Services, one of the world’s most advanced data-driven health systems. The Clalit integrated infrastructure connects hospitals, clinics, and community health programs through longitudinal datasets that support predictive analytics at the national scale.

Experience within such systems reinforces an important insight: artificial intelligence models do not function independently of human judgment. They reflect priorities embedded in their design and the assumptions guiding their deployment.

“Algorithms are opinions embedded in code,” Balicer has observed in discussions about the role of artificial intelligence in population health.

In practice, this means that AI systems interpret clinical data through frameworks shaped by human choices. The way a model defines risk, prioritizes cases, or recommends interventions reflects decisions about what matters most within a healthcare environment.

Those decisions carry ethical implications. When artificial intelligence helps determine which patients receive immediate attention or which cases are escalated for further review, transparency about how algorithms function becomes essential to maintaining trust among clinicians and patients alike. The scientific frontier of health-care AI reinforces that concern.

Isaac Kohane, MD, PhD, who has also served as a co-author of the Institute of Medicine Report on Precision Medicine, which has served as the template for national efforts, has spent decades exploring how machine learning can advance medicine while preserving the judgment that defines clinical practice. His research emphasizes that artificial intelligence in healthcare must align with the ethical traditions and professional responsibilities of medicine.

“AI systems in medicine must ultimately reflect the values of the profession they serve,” Kohane has written in discussions about AI alignment in biomedical informatics.

This perspective highlights a crucial distinction between technological capability and clinical responsibility. Many AI models entering healthcare environments were originally designed for broader computational tasks rather than the nuanced realities of patient care. Medicine operates within a landscape shaped by uncertainty, empathy, and accountability, and technologies introduced into that environment must reflect those values.

Ensuring that artificial intelligence aligns with the principles guiding health-care delivery, therefore, represents one of the most important scientific and ethical challenges facing the future of health.

The Discipline Required to Make Innovation Matter

The health sector has experienced waves of technological enthusiasm before. Electronic health records promised seamless information exchange, but then introduced administrative burdens on health professionals when implemented without thoughtful workflow design. Data analytics promised unprecedented insight, but sometimes led to fragmentation when systems failed to communicate across institutions.

Artificial intelligence now stands at a similar moment in the evolution of health technology.

Its capabilities in supporting decision-making flow are extraordinary, yet realizing them will require disciplined leadership to evaluate, integrate and govern AI tools within health-care delivery systems. Health leaders must learn to ask deeper questions before embracing the next algorithmic breakthrough. What problem does this system truly solve? How does it strengthen clinical practice? What assumptions guide its recommendations? How does its use advance the mission of improving patient health?

These questions move the conversation beyond technological novelty toward operational practicality. It’s among the many reasons these three global leaders step to the HIMSS stage together.

Artificial intelligence will undoubtedly reshape the health ecosystem in the years ahead. Its long-term impact, however, will not be determined solely by the sophistication of algorithms or the speed of technological progress. Along with how to leverage AI, ChatGPT and LLMs, users require heightened cognitive awareness.

It will be determined by whether the health community develops the discipline and ability required to translate innovation into systems that strengthen care, support clinicians and improve the health of the populations they serve.

The real story of artificial intelligence in health is no longer about what machines can do. It is about how wisely the health sector chooses to use them.

The post From AI Excitement to Execution: Why Health Leaders Must Now Master the “How” appeared first on Medika Life.

That moment, when the T-800, a machine built for destruction, understands human emotion, is among the most powerful in action cinema. It is the climax of Terminator 2: Judgment Day, but also a beginning: the start of the android’s transformation, not into a human, but into something more self-conscious that recognizes the worth of organic life, even if it can outthink people, it can appreciate the human experience.

The metaphor feels timely as we stand at the edge of an AI-driven health future. Today’s GenAI tools are evolving rapidly, but are we, their creators and coders, evolving with equal intentionality? Are we teaching the owners of these systems why we heal, or just how?

We often speak of artificial intelligence as if it were separate from us. But AI is not alien. It is us—our ideas, data, values—encoded and amplified. It mirrors back what we feed it. In the realm of health, that reflection must be carefully considered. Unlike a Hollywood villain, GenAI doesn’t turn against us with malicious intent. But it can misalign from its purpose if we forget that behind every innovation must be a human-centered goal.

From the first recorded prayer for healing in the Bible—“G-d, please heal her now”—health has always been rooted in empathy, intuition, and relationships. The clinician’s pause before giving a diagnosis, the nurse’s touch when comforting a patient, and the community health worker navigating skepticism in underserved areas are not functions you can replicate with an algorithm. They are acts of presence, of judgment shaped by experience and emotion. Yet, technology now surrounds these moments, offering powerful new support.

Even Satya Nadella, CEO of Microsoft, captured this imperative clearly: “Empathy must be embedded in artificial intelligence from the moment it is created to ensure it becomes a positive force in people’s lives.” It’s not just about what technology can do—it’s about how it’s directed, and who it serves.

GenAI is already beginning to assist clinical teams by synthesizing medical records, supporting drug discovery, and interpreting diagnostic images faster than human eyes. It scales knowledge, translates complex science for patients, and identifies early signals of population health risks. These are welcome advancements—but only when guided by a human compass.

Let’s not look at a future of “us vs. them”—patients and providers versus machines. The more accurate framing is “us and them”: a coalition of human and machine intelligence, working together in the service of healing. Patients, payers, providers, product developers, and policymakers are the “us.” GenAI, LLMs, machine learning, and chatbots form the “them.” Power lies not in one side dominating the other, but in how we integrate these efforts.

Tim Cook, CEO of Apple, has often said, “At Apple, we believe technology should lift humanity.” In a world driven by rapid innovation, his words are a steady reminder that progress without purpose is not progress—it’s motion without meaning. Cook also noted at MIT, “Technology is capable of doing great things, but it doesn’t want to do great things. It doesn’t want anything … That part takes all of us.”

To do that, we must resist the urge to see AI as an all-knowing oracle. AI is not autonomous in values, does not possess a conscience, and lacks intuition unless we teach it patterns. Those patterns, if drawn from biased data, can replicate systemic inequities. In health, where trust is everything, we cannot afford such blind spots. Human oversight is not just necessary, it’s irreplaceable.

There’s also a danger in assuming technology alone can fix what’s broken. We already know the limits of scale without empathy. We’ve seen systems become more efficient but less personal. We’ve witnessed patients lost in data flows, their lived experience reduced to metrics. If GenAI becomes another layer of distance rather than connection, we will have failed to grasp its most powerful potential: to bring clarity, not complexity; to extend human capacity, not replace it.

OpenAI CEO Sam Altman acknowledges the promise and the peril: “This will be the greatest technology humanity has yet developed… We’ve got to be careful here … people should be happy that we are a little bit scared of this.” Fear, in this case, signals responsibility. Responsibility requires centering AI in the service of people, not pushing people to conform to the logic of machines.

There are lessons in Terminator beyond the thrill of a dystopian chase. Sarah Connor learns to trust the very machine that once tried to kill her. John Connor, the future leader of humanity, becomes the teacher. And the T-800—a symbol of cold efficiency—becomes the student. This reversal reflects what we need now: machines that learn how to act and why their actions matter, not just how to optimize workflows but why saving time matters when time is the difference between life and death.

We cannot forget how this transformation from killer machine to protector occurs. In “Terminator 2: Judgment Day,” the T-800 model evolves into humanity’s hero because John Connor reprograms it from the future to protect his younger self and his mother, Sarah Connor. The human is the creator—the coder.

Somewhere in this cinematic science fiction lies a guiding truth for our future reality: technology learns from humanity. Just as this version of the Terminator changed by being close to people, our AI systems will evolve based on what—and who—they are near. If surrounded by empathy, equity, and ethical standards, they can amplify what’s best in us. If left untethered from human purpose, they risk scaling our worst habits.

We often frame digital health progress in terms of speed and scale. But what if we reframed it through the lens of dignity? What if the measure of innovation wasn’t just how fast a model can generate results, but how well it supports the human healing experience?

In the end, the T-800 sacrifices itself to protect a better future. It understands that some decisions aren’t logical; they are meaningful. It doesn’t cry—but it finally sees why we do.

Let’s not wait for machines to catch up with our humanity. Let’s lead with it.

The post It’s Not Us vs. Them: What the Terminator Teaches Us About AI and the Future of Health appeared first on Medika Life.